| Financial Year |
March 31 2023 |
| Monetary Funds |
778,717,927.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
317,065,909.14 |
| Accounts Receivable |
528,221,160.49 |
| Advances to Suppliers |
23,189,435.50 |
| Other Receivables |
7,511,521.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
385,880,271.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,020,464.45 |
| Total Current Assets |
2,102,606,690.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
106,048,955.06 |
| Investment Properties |
-- |
| Fixed Assetes |
1,410,714,877.89 |
| Under-construction Projects |
50,626,228.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
160,777,648.12 |
| R&D expenses |
-- |
| Goodwill |
141,718.51 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
27,325,004.30 |
| Other Non-Current Assets |
3,489,053.00 |
| Sub-Total of Non-Current Assets |
1,759,766,185.40 |
| Total Assets |
3,862,372,875.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
158,623,238.49 |
| Accounts Payable |
184,996,094.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,274,768.17 |
| Taxes Payable |
7,547,219.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,741,644.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
98,260,608.47 |
| Other Current Liabilities |
11,883,748.58 |
| Sub-Total of Current Liabilities |
586,740,796.22 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
451,605,205.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
456,584,761.89 |
| Total Liabilities |
1,043,325,558.11 |
| Paid-In Capital(Or Share Stock) |
977,360,000.00 |
| Capital Surplus |
563,801,111.38 |
| Surplus Reserve |
164,481,667.76 |
| LESS:Treasury Stock |
40,829,747.93 |
| Undistributed Profits |
1,153,213,468.55 |
| Minority Stockholder's Interest |
1,020,817.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,818,026,499.76 |
| Owner's Equity（Stockholder's Equity） |
2,819,047,317.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,862,372,875.48 |
